F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (297 views)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 2.415, 5-year impact factor: 2.63
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84889884838&partnerID=40&md5=90f4c16019b4661d48ac27d3f703220d
Keywords: [f-18]fdg Pet Ct, Colorectal Cancer, Loco-Regional Relapse, Quantitative Assessment, Carcinoembryonic Antigen, Fluorodeoxyglucose F 18, Adult, Aged, Article, Cancer Prognosis, Clinical Article, Colorectal Surgery, Computer Assisted Emission Tomography, Female, Human, Middle Aged, Overall Survival, Pet-Ct Scanner, Priority Journal, Quantitative Analysis, Radioactivity, Receiver Operating Characteristic, Risk Factor, Survival Time, Very Elderly, 80 And Over, Colorectal Neoplasms, Endpoint Determination, Follow-Up Studies, Kaplan-Meier Estimate, Logistic Models, Multivariate Analysis, Positron-Emission Tomography, Roc Curve, X-Ray Computed, Carcinoembryonic Antigen Blood, Colorectal Neoplasms Blood Radiography Radionuclide Imaging Surgery, Fluorodeoxyglucose F18 Diagnostic Use, [f-18] Fdg Pet Ct,
Affiliations:
*** IBB - CNR ***
Istituto di Ricerca e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Rionero in Vulture, Italy
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche (CNR), Naples, Italy
University of Texas, Southwestern, Dallas, United States
Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Via P. Pio 1, 85028 Rionero in Vulture, Italy
References:
Chua, T.C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10.1097/COC.0b013e3181fe444
Domati, F., Rossi, G., Benatti, P., Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life (2011) Intern Emerg Med, 6, pp. 529-535. , 21512795 10.1007/s11739-011-0590-y
Jemal, A., Tiwari, R.C., Murray, T., Cancer Statistics, 2004 (2004) CA Cancer J Clin, 54, pp. 8-29. , 14974761 10.3322/canjclin.54.1.8
Bipat, S., Niekel, M.C., Comans, E.F., Imaging modalities for the staging of patients with colorectal cancer (2012) Neth J Med, 70, pp. 26-34. , 22271811 1:STN:280:DC%2BC387ntFygsQ%3D%3D
Shen, Y.Y., Liang, J.A., Chen, Y.K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A.R., Nahas, S.C., Camargo, E.E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10.1016/j.jsurg.2006.11.004
Lu, Y.Y., Chen, J.H., Chien, C.R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Giorgetti, A., Sorace, O., Pisani, P., Accuracy of qualitative and semiquantitative analysis of 18FDG positron emission tomography scans in the evaluation of primary and metastatic lesions (2000) Clin Positron Imaging, 3, p. 182. , 11150785 10.1016/S1095-0397(00)00094-7
Kelley, R.K., Van Bebber, S.L., Phillips, K.A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T.A., McDonald, P.J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10.1007/s003840050188 1:STN:280:DyaK1M3isVWnsQ%3D%3D
Brethauer, S.A., Magrino, T.J., Riffenburgh, R.H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10.1046/j.1463-1318.2002.00327.x 10.1046/j.1463-1318.2002.00327.x
Even-Sapir, E., Parag, Y., Lerman, H., Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection (2004) Radiology, 232, pp. 815-822. , 10.1148/radiol.2323031065 15273334 10.1148/radiol.2323031065
Mainenti, P.P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10.3748/wjg.v17.i11.1427
Wiggers, T., Mannaerts, G.H., Marinelli, A.W., Surgery for locally recurrent rectal cancer (2003) Colorectal Dis, 5, pp. 504-507. , 12925090 10.1046/j.1463-1318.2003.00507.x 1:STN:280: DC%2BD3szovVemsw%3D%3D
Kyoto, Y., Momose, M., Kondo, C., Ability of F-18-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations (2010) Ann Nucl Med, 24, pp. 395-401. , 20364373 10.1007/s12149-010-0372-z 1:CAS:528:DC%2BC3cXhtVertL7L
Shreve, P.D., Anzai, Y., Wahl, R.L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10.1148/radiographics.19.1.g99ja0761 1:STN:280: DyaK1M7it1yjsw%3D%3D
Quirce Pisano, R., Banzo Marraco, I., Jiménez-Bonilla, J.F., Potential sources of diagnostic pitfall and variants in FDG-PET/CT (2008) Rev Esp Med Nucl, 27, pp. 130-159. , 18367053 10.1157/13117196 1:STN:280:DC%2BD1c3gvFarug%3D%3D
Culverwell, A.D., Scarsbrook, A.F., Chowdhury, F.U., False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10.1016/j.crad.2010.12.004 1:STN:280:DC%2BC3M3isFantg%3D%3D
Shihab, O.C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10.1002/bjs.7662 1:STN:280: DC%2BC3MbksVOitw%3D%3D
Patel, U.B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10.1200/JCO.2011.34.9068
Willett, C., Tepper, J.E., Cohen, A., Local failure following curative resection of colonic adenocarcinoma (1984) Int J Radiat Oncol Biol Phys, 10, pp. 645-651. , 6735753 10.1016/0360-3016(84)90295-5 1:STN:280:DyaL2c3jvFWhtg%3D%3D
Pilipshen, S.J., Heilweil, M., Quan, S.H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10.1002/1097-0142(19840315)53:6<1354: AID-CNCR2820530623> 3. 0.CO
2-J 1:STN:280:DyaL2c7gs1ersA%3D%3D
Read, T.E., Mutch, M.G., Chang, B.W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10.1016/S1072-7515(02)01224-3
Hasegawa, J., Nishimura, J., Yamamoto, S., Exfoliated malignant cells at the anastomosis site in colon cancer surgery: The impact of surgical bowel occlusion and intraluminal cleaning (2011) Int J Colorectal Dis, 26, pp. 875-880. , 21302117 10.1007/s00384-011-1148-1
Petersen, S., Freitag, M., Hellmich, G., Anastomotic leakage: Impact on local recurrence and survival in surgery of colorectal cancer (1998) Int J Colorectal Dis, 13, pp. 160-163. , 9810519 10.1007/s003840050158 1:STN:280:DyaK1M%2FivVaitg%3D%3D
Flanagan, F.L., Dehdashti, F., Ogunbiyi, O.A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10.1097/00000658-199803000-00001 1:STN:280:DyaK1c7os1arsw%3D%3D
Maldonado, A., Sancho, F., Cerdan, J., FDG-PET in the detection of recurrence in colorectal cancer based on rising CEA level. Experience in 72 patients (2000) Clin Positron Imaging, 3, p. 170. , 11150773 10.1016/S1095-0397(00)00082-0
Flamen, P., Hoekstra, O.S., Homans, F., Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET) (2001) Eur J Cancer, 37, pp. 862-869. , 11313174 10.1016/S0959-8049(01)00049-1 1:CAS:528:DC%2BD3MXislGhtbw%3D
Libutti, S.K., Alexander, Jr.H.R., Choyke, P., A prospective study of 2-[F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10.1007/s10434-001-0779-9 1:STN:280:DC%2BD38%2FkvVynsw%3D%3D
Zervos, E.E., Badgwell, B.D., Burak, Jr.W.E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10.1067/msy.2001.116919 1:STN:280:DC%2BD3Mrls1WhtQ%3D%3D
Smeets, P., Ham, H., Ceelen, W., Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data (2010) Q J Nucl Med Mol Imaging, 54, pp. 327-332. , 20639817 1:STN:280:DC%2BC3cnoslahsg%3D%3D
Simo, M., Lomena, F., Setoain, J., FDG-PET improves the management of patients with suspected recurrence of colorectal cancer (2002) Nucl Med Commun, 23, pp. 975-982. , 12352596 10.1097/00006231-200210000-00007 1:CAS:528:DC%2BD38XnsVarsrc%3D
Chua, T. C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10. 1097/COC. 0b013e3181fe444
Shen, Y. Y., Liang, J. A., Chen, Y. K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A. R., Nahas, S. C., Camargo, E. E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10. 1016/j. jsurg. 2006. 11. 004
Lu, Y. Y., Chen, J. H., Chien, C. R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Kelley, R. K., Van Bebber, S. L., Phillips, K. A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T. A., McDonald, P. J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10. 1007/s003840050188 1: STN: 280: DyaK1M3isVWnsQ%3D%3D
Brethauer, S. A., Magrino, T. J., Riffenburgh, R. H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10. 1046/j. 1463-1318. 2002. 00327. x 10. 1046/j. 1463-1318. 2002. 00327. x
Mainenti, P. P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10. 3748/wjg. v17. i11. 1427
Shreve, P. D., Anzai, Y., Wahl, R. L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10. 1148/radiographics. 19. 1. g99ja0761 1: STN: 280: DyaK1M7it1yjsw%3D%3D
Culverwell, A. D., Scarsbrook, A. F., Chowdhury, F. U., False-positive uptake on 2- [18F] -fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10. 1016/j. crad. 2010. 12. 004 1: STN: 280: DC%2BC3M3isFantg%3D%3D
Shihab, O. C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10. 1002/bjs. 7662 1: STN: 280: DC%2BC3MbksVOitw%3D%3D
Patel, U. B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10. 1200/JCO. 2011. 34. 9068
Pilipshen, S. J., Heilweil, M., Quan, S. H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10. 1002/1097-0142 (19840315) 53: 6<1354: AID-CNCR2820530623> 3. 0. CO
2-J 1: STN: 280: DyaL2c7gs1ersA%3D%3D
Read, T. E., Mutch, M. G., Chang, B. W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10. 1016/S1072-7515 (02) 01224-3
Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10. 1097/00000658-199803000-00001 1: STN: 280: DyaK1c7os1arsw%3D%3D
Libutti, S. K., Alexander, Jr. H. R., Choyke, P., A prospective study of 2- [F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10. 1007/s10434-001-0779-9 1: STN: 280: DC%2BD38%2FkvVynsw%3D%3D
Zervos, E. E., Badgwell, B. D., Burak, Jr. W. E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10. 1067/msy. 2001. 116919 1: STN: 280: DC%2BD3Mrls1WhtQ%3D%3D
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 2.415, 5-year impact factor: 2.63
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84889884838&partnerID=40&md5=90f4c16019b4661d48ac27d3f703220d
Keywords: [f-18]fdg Pet Ct, Colorectal Cancer, Loco-Regional Relapse, Quantitative Assessment, Carcinoembryonic Antigen, Fluorodeoxyglucose F 18, Adult, Aged, Article, Cancer Prognosis, Clinical Article, Colorectal Surgery, Computer Assisted Emission Tomography, Female, Human, Middle Aged, Overall Survival, Pet-Ct Scanner, Priority Journal, Quantitative Analysis, Radioactivity, Receiver Operating Characteristic, Risk Factor, Survival Time, Very Elderly, 80 And Over, Colorectal Neoplasms, Endpoint Determination, Follow-Up Studies, Kaplan-Meier Estimate, Logistic Models, Multivariate Analysis, Positron-Emission Tomography, Roc Curve, X-Ray Computed, Carcinoembryonic Antigen Blood, Colorectal Neoplasms Blood Radiography Radionuclide Imaging Surgery, Fluorodeoxyglucose F18 Diagnostic Use, [f-18] Fdg Pet Ct,
Affiliations:
*** IBB - CNR ***
Istituto di Ricerca e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Rionero in Vulture, Italy
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche (CNR), Naples, Italy
University of Texas, Southwestern, Dallas, United States
Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Via P. Pio 1, 85028 Rionero in Vulture, Italy
References:
Chua, T.C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10.1097/COC.0b013e3181fe444
Domati, F., Rossi, G., Benatti, P., Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life (2011) Intern Emerg Med, 6, pp. 529-535. , 21512795 10.1007/s11739-011-0590-y
Jemal, A., Tiwari, R.C., Murray, T., Cancer Statistics, 2004 (2004) CA Cancer J Clin, 54, pp. 8-29. , 14974761 10.3322/canjclin.54.1.8
Bipat, S., Niekel, M.C., Comans, E.F., Imaging modalities for the staging of patients with colorectal cancer (2012) Neth J Med, 70, pp. 26-34. , 22271811 1:STN:280:DC%2BC387ntFygsQ%3D%3D
Shen, Y.Y., Liang, J.A., Chen, Y.K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A.R., Nahas, S.C., Camargo, E.E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10.1016/j.jsurg.2006.11.004
Lu, Y.Y., Chen, J.H., Chien, C.R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Giorgetti, A., Sorace, O., Pisani, P., Accuracy of qualitative and semiquantitative analysis of 18FDG positron emission tomography scans in the evaluation of primary and metastatic lesions (2000) Clin Positron Imaging, 3, p. 182. , 11150785 10.1016/S1095-0397(00)00094-7
Kelley, R.K., Van Bebber, S.L., Phillips, K.A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T.A., McDonald, P.J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10.1007/s003840050188 1:STN:280:DyaK1M3isVWnsQ%3D%3D
Brethauer, S.A., Magrino, T.J., Riffenburgh, R.H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10.1046/j.1463-1318.2002.00327.x 10.1046/j.1463-1318.2002.00327.x
Even-Sapir, E., Parag, Y., Lerman, H., Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection (2004) Radiology, 232, pp. 815-822. , 10.1148/radiol.2323031065 15273334 10.1148/radiol.2323031065
Mainenti, P.P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10.3748/wjg.v17.i11.1427
Wiggers, T., Mannaerts, G.H., Marinelli, A.W., Surgery for locally recurrent rectal cancer (2003) Colorectal Dis, 5, pp. 504-507. , 12925090 10.1046/j.1463-1318.2003.00507.x 1:STN:280: DC%2BD3szovVemsw%3D%3D
Kyoto, Y., Momose, M., Kondo, C., Ability of F-18-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations (2010) Ann Nucl Med, 24, pp. 395-401. , 20364373 10.1007/s12149-010-0372-z 1:CAS:528:DC%2BC3cXhtVertL7L
Shreve, P.D., Anzai, Y., Wahl, R.L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10.1148/radiographics.19.1.g99ja0761 1:STN:280: DyaK1M7it1yjsw%3D%3D
Quirce Pisano, R., Banzo Marraco, I., Jiménez-Bonilla, J.F., Potential sources of diagnostic pitfall and variants in FDG-PET/CT (2008) Rev Esp Med Nucl, 27, pp. 130-159. , 18367053 10.1157/13117196 1:STN:280:DC%2BD1c3gvFarug%3D%3D
Culverwell, A.D., Scarsbrook, A.F., Chowdhury, F.U., False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10.1016/j.crad.2010.12.004 1:STN:280:DC%2BC3M3isFantg%3D%3D
Shihab, O.C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10.1002/bjs.7662 1:STN:280: DC%2BC3MbksVOitw%3D%3D
Patel, U.B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10.1200/JCO.2011.34.9068
Willett, C., Tepper, J.E., Cohen, A., Local failure following curative resection of colonic adenocarcinoma (1984) Int J Radiat Oncol Biol Phys, 10, pp. 645-651. , 6735753 10.1016/0360-3016(84)90295-5 1:STN:280:DyaL2c3jvFWhtg%3D%3D
Pilipshen, S.J., Heilweil, M., Quan, S.H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10.1002/1097-0142(19840315)53:6<1354: AID-CNCR2820530623> 3. 0.CO
2-J 1:STN:280:DyaL2c7gs1ersA%3D%3D
Read, T.E., Mutch, M.G., Chang, B.W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10.1016/S1072-7515(02)01224-3
Hasegawa, J., Nishimura, J., Yamamoto, S., Exfoliated malignant cells at the anastomosis site in colon cancer surgery: The impact of surgical bowel occlusion and intraluminal cleaning (2011) Int J Colorectal Dis, 26, pp. 875-880. , 21302117 10.1007/s00384-011-1148-1
Petersen, S., Freitag, M., Hellmich, G., Anastomotic leakage: Impact on local recurrence and survival in surgery of colorectal cancer (1998) Int J Colorectal Dis, 13, pp. 160-163. , 9810519 10.1007/s003840050158 1:STN:280:DyaK1M%2FivVaitg%3D%3D
Flanagan, F.L., Dehdashti, F., Ogunbiyi, O.A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10.1097/00000658-199803000-00001 1:STN:280:DyaK1c7os1arsw%3D%3D
Maldonado, A., Sancho, F., Cerdan, J., FDG-PET in the detection of recurrence in colorectal cancer based on rising CEA level. Experience in 72 patients (2000) Clin Positron Imaging, 3, p. 170. , 11150773 10.1016/S1095-0397(00)00082-0
Flamen, P., Hoekstra, O.S., Homans, F., Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET) (2001) Eur J Cancer, 37, pp. 862-869. , 11313174 10.1016/S0959-8049(01)00049-1 1:CAS:528:DC%2BD3MXislGhtbw%3D
Libutti, S.K., Alexander, Jr.H.R., Choyke, P., A prospective study of 2-[F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10.1007/s10434-001-0779-9 1:STN:280:DC%2BD38%2FkvVynsw%3D%3D
Zervos, E.E., Badgwell, B.D., Burak, Jr.W.E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10.1067/msy.2001.116919 1:STN:280:DC%2BD3Mrls1WhtQ%3D%3D
Smeets, P., Ham, H., Ceelen, W., Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data (2010) Q J Nucl Med Mol Imaging, 54, pp. 327-332. , 20639817 1:STN:280:DC%2BC3cnoslahsg%3D%3D
Simo, M., Lomena, F., Setoain, J., FDG-PET improves the management of patients with suspected recurrence of colorectal cancer (2002) Nucl Med Commun, 23, pp. 975-982. , 12352596 10.1097/00006231-200210000-00007 1:CAS:528:DC%2BD38XnsVarsrc%3D
Chua, T. C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10. 1097/COC. 0b013e3181fe444
Shen, Y. Y., Liang, J. A., Chen, Y. K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A. R., Nahas, S. C., Camargo, E. E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10. 1016/j. jsurg. 2006. 11. 004
Lu, Y. Y., Chen, J. H., Chien, C. R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Kelley, R. K., Van Bebber, S. L., Phillips, K. A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T. A., McDonald, P. J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10. 1007/s003840050188 1: STN: 280: DyaK1M3isVWnsQ%3D%3D
Brethauer, S. A., Magrino, T. J., Riffenburgh, R. H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10. 1046/j. 1463-1318. 2002. 00327. x 10. 1046/j. 1463-1318. 2002. 00327. x
Mainenti, P. P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10. 3748/wjg. v17. i11. 1427
Shreve, P. D., Anzai, Y., Wahl, R. L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10. 1148/radiographics. 19. 1. g99ja0761 1: STN: 280: DyaK1M7it1yjsw%3D%3D
Culverwell, A. D., Scarsbrook, A. F., Chowdhury, F. U., False-positive uptake on 2- [18F] -fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10. 1016/j. crad. 2010. 12. 004 1: STN: 280: DC%2BC3M3isFantg%3D%3D
Shihab, O. C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10. 1002/bjs. 7662 1: STN: 280: DC%2BC3MbksVOitw%3D%3D
Patel, U. B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10. 1200/JCO. 2011. 34. 9068
Pilipshen, S. J., Heilweil, M., Quan, S. H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10. 1002/1097-0142 (19840315) 53: 6<1354: AID-CNCR2820530623> 3. 0. CO
2-J 1: STN: 280: DyaL2c7gs1ersA%3D%3D
Read, T. E., Mutch, M. G., Chang, B. W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10. 1016/S1072-7515 (02) 01224-3
Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10. 1097/00000658-199803000-00001 1: STN: 280: DyaK1c7os1arsw%3D%3D
Libutti, S. K., Alexander, Jr. H. R., Choyke, P., A prospective study of 2- [F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10. 1007/s10434-001-0779-9 1: STN: 280: DC%2BD38%2FkvVynsw%3D%3D
Zervos, E. E., Badgwell, B. D., Burak, Jr. W. E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10. 1067/msy. 2001. 116919 1: STN: 280: DC%2BD3Mrls1WhtQ%3D%3D
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer
Purpose: We evaluated the role of quantitative assessment by maximum standardized uptake value (SUVmax) on F-18 fluorodeoxyglucose [F-18]FDG positron emission tomography/computed tomography (PET/CT) in stratifying colorectal cancer (CRC) patients with unexplained carcinoembryonic antigen (CEA) rise after surgical curative resection. Material and methods: Forty asymptomatic patients (mean age, 64 ± 12 years) with previous CRC and current serum CEA levels >5 ng/ml underwent [F-18] FDG PET/CT 13 ± 3 months after complete surgical resection. The SUVmax was registered on anastomosis and peri-anastomotic tissue lesions, if present. The patients were followed for 24 ± 9 months thereafter. Re-intervention, evidence of newly discovered distant metastases, and death were recognized as main events and constituted surrogate end points. The receiver-operator-curve (ROC) analysis was performed to estimate the optimal SUVmax cut-off to predict patients at high risk of main events. PET/CT results were then related to disease outcome (overall survival; OS). Results: The mean SUVmax at the anastomotic site was 6.2 ± 3 (range 2.6-15). At multivariate logistic regression analysis, the anastomotic SUVmax remained as the only significant contributor to the prediction of the events (p = 0.004; OR 1.97). The ROC analysis recognized that the optimal threshold of SUVmax to differentiate patients was 5.7. A worse OS was observed in patients presenting with a SUVmax greater than 5.7 as compared to those having lesser (median survival: 16 vs. 31 months; p = 0.002). Conclusions: The quantitative assessment by SUVmax on [F-18]FDG PET/CT may be helpful in patients presenting with unexplained CEA rise after curative resection of CRC, by identifying those at risk of main events. © 2013 Springer-Verlag Berlin Heidelberg.
Purpose: We evaluated the role of quantitative assessment by maximum standardized uptake value (SUVmax) on F-18 fluorodeoxyglucose [F-18]FDG positron emission tomography/computed tomography (PET/CT) in stratifying colorectal cancer (CRC) patients with unexplained carcinoembryonic antigen (CEA) rise after surgical curative resection. Material and methods: Forty asymptomatic patients (mean age, 64 ± 12 years) with previous CRC and current serum CEA levels >5 ng/ml underwent [F-18] FDG PET/CT 13 ± 3 months after complete surgical resection. The SUVmax was registered on anastomosis and peri-anastomotic tissue lesions, if present. The patients were followed for 24 ± 9 months thereafter. Re-intervention, evidence of newly discovered distant metastases, and death were recognized as main events and constituted surrogate end points. The receiver-operator-curve (ROC) analysis was performed to estimate the optimal SUVmax cut-off to predict patients at high risk of main events. PET/CT results were then related to disease outcome (overall survival; OS). Results: The mean SUVmax at the anastomotic site was 6.2 ± 3 (range 2.6-15). At multivariate logistic regression analysis, the anastomotic SUVmax remained as the only significant contributor to the prediction of the events (p = 0.004; OR 1.97). The ROC analysis recognized that the optimal threshold of SUVmax to differentiate patients was 5.7. A worse OS was observed in patients presenting with a SUVmax greater than 5.7 as compared to those having lesser (median survival: 16 vs. 31 months; p = 0.002). Conclusions: The quantitative assessment by SUVmax on [F-18]FDG PET/CT may be helpful in patients presenting with unexplained CEA rise after curative resection of CRC, by identifying those at risk of main events. © 2013 Springer-Verlag Berlin Heidelberg.
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer
| ▼ High-resolution positron emission tomography of the ischaemic mouse heart |
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer
Other filter: ([btitle,keywords] "[f-18]fdg Pet Ct" OR ...
Pramanik A, Xu Z, Shamsuddin SH, Khaled YS, Ingram N, Maisey T, Tomlinson D, Coletta PL, Jayne D, Hughes TA, Tyler AII, Millner PA
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models (3 views)
Acs Appl Mater Interfaces (ISSN: 1944-8252electronic), 2022 Mar 09; 14 (9 ): 11078-11091.
Impact Factor:
View Export to BibTeX Export to EndNote
Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F, Fagoonee S
* The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells (4 views)
Cancers (ISSN: 2072-6694linking), 2021 Aug 13; 13(16): N/D-N/D.
Impact Factor: 6.126
View Export to BibTeX Export to EndNote
Susana F, Fagoonee S, Alessandro S, Valentina G, Chiara R, Marco P, Fiorella A, Danilo D
* Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring (82 views)
Talanta (ISSN: 0039-9140linking), 2021 Jan 15; 222: 121441-121441.
Impact Factor: 5.339
View Export to BibTeX Export to EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (149 views) (PDF 45 views)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
View Export to BibTeX Export to EndNote
Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, Altruda F, Fagoonee S
* Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells (128 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2020 Jan 16; 21 (2 ): N/D-N/D.
Impact Factor: 2.598
View Export to BibTeX Export to EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (133 views)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
View Export to BibTeX Export to EndNote
Barresi V, Valenti G, Spampinato G, Musso N, Castorina S, Rizzarelli E, Condorelli DF
* Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer (185 views)
J Cell Biochem (ISSN: 0730-2312linking), 2018 Dec; 119(12): 9707-9719.
Impact Factor: 2.959
View Export to BibTeX Export to EndNote
Di Lascio N, Avigo C, Salvati A, Martini N, Ragucci M, Monti S, Prinster A, Chiappino D, Mancini M, D'Elia D, Ghiadoni L, Bonino F, Brunetto MR, Faita F
* Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging (427 views)
Ultrasound Med Biol (ISSN: 0301-5629, 0301-5629linking), 2018; 44(8): 1585-1596.
Impact Factor: 2.494
View Export to BibTeX Export to EndNote
Caprio MG, Simonetti I, Tarotto L, Trovato P, Mainolfi CG, Salvatore B, Pace L
* 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (163 views) (PDF 157 views)
Int J Of Current Res, 2017 Jul; 9: 53960-53964.
Impact Factor: 7.086
View Export to BibTeX Export to EndNote
Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (365 views)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2016 Dec 28; 8(6): 10007-10024.
Impact Factor: 5.168
View Export to BibTeX Export to EndNote
Caviglia GP, Cabianca L, Fagoonee S, Gili FM
* Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase (329 views)
Biochem Medica (ISSN: 1330-0962), 2016; 26(1): 114-120.
Impact Factor: 2.934
View Export to BibTeX Export to EndNote
Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, Vita G, Venetucci A, Di Cosola M, Barbato F, Storto G
* [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients (219 views)
Radiol Oncol (ISSN: 1318-2099), 2015 Nov 27; 49(4): 320-326.
Impact Factor: 1.736
View Export to BibTeX Export to EndNote
Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S
* Non-invasive diagnostic imaging of colorectal liver metastases (254 views)
World J Radiol (ISSN: 1949-8470electronic, 1949-8470linking), 2015 Jul 28; 7(7): 157-169.
Impact Factor: 0.567
View Export to BibTeX Export to EndNote
Petretta M, Storto G, Pellegrino T, Bonaduce D, Cuocolo A
* Quantitative Assessment of Myocardial Blood Flow with SPECT (380 views)
Prog Cardiovasc Dis (ISSN: 0033-0620), 2015 Jan 3; 57(6): 607-614.
Impact Factor: 4.635
View Export to BibTeX Export to EndNote
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (397 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S425-S425.
Impact Factor: 5.537
View Export to BibTeX Export to EndNote
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (409 views)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
View Export to BibTeX Export to EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (531 views)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
View Export to BibTeX Export to EndNote
Napolitano S, Troiani T, Morgillo F, Ciardiello F, Belli G, Cioffi L, Sirignano C, Martinelli E
* Predictive Biomarkers To Anti-Egfr Inhibitors Treatment In The Management Of Metastatic Colorectal Cancer (245 views) (PDF 12 views)
Journal Of Carcinogenesis & Mutagenesis, 2014; N/D: 2157-2518.
Impact Factor: 3.445
View Export to BibTeX Export to EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (672 views)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
View Export to BibTeX Export to EndNote
Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (334 views)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
View Export to BibTeX Export to EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (442 views)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
View Export to BibTeX Export to EndNote
Matrone A, Russo M, Mollica C, Lombardi D, Lombardi G, Maurea S, Imbriaco M
* Lymphoepithelial pancreatic cyst: an atypical benign pancreatic mass presenting with a "cheerios-like" appearance (315 views)
Jop (ISSN: 1590-8577, 1590-0857), 2010 Mar 5; 11(2): 170-172.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro, Merlino A, Graziano G, Colantuoni V
* A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia (410 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Impact Factor: 2.773
View Export to BibTeX Export to EndNote
Lucignani G, Cuocolo A
Advances in quantitative assessment of myocardial blood flow and coronary reserve (230 views)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2009 Oct; 36(10): 1687-1692.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (250 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (371 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (250 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
View Export to BibTeX Export to EndNote
Mainenti PP, Cirillo LC, Camera L, Persico F, Cantalupo T, Pace L, De Palma GD, Persico G, Salvatore M
* Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer (321 views)
Eur J Radiol (ISSN: 0720-048x), 2006 Dec; 60(3): 453-459.
Impact Factor: 1.332
View Export to BibTeX Export to EndNote
Caprio MG, Cantalupo T, Mainenti PP, Mainolfi CG, Varrone A, Salvatore B, Persico F, D'Antonio D, Pace L, Salvatore M
* 18F-fdg pet, pet/ct and ce-mdct in locally advanced colorectal cancer (282 views) (PDF 157 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Storto G, Mainenti PP, Varrone A, Mainolfi C, Salvatore B, Caprio MG, Cella L, Soricelli A, Pace L, Salvatore M
* Role of FDG-PET/CT in the staging of colorectal cancer (382 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Mainenti PP, Romano M, Imbriaco M, Camera L, Pace L, D'Antonio D, Bucci L, Galloro G, Salvatore M
* Added value of CT colonography after a positive conventional colonoscopy: Impact on treatment strategy (401 views)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2005 Jan; 30(1): 42-47.
Impact Factor: 1.034
View Export to BibTeX Export to EndNote
Salvatore M, Fonti R
* New frontiers of nuclear medicine (455 views)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 May; 88(3): S60-S60.
Impact Factor: 0.267
View Export to BibTeX Export to EndNote
Esposito G, Tempesta A, Galati MG, De Bellis M, Rossi GB, Potena MI, Marone P, Daniele B, Del Vecchio S
Mucosal expression of carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with gastritis and gastric cancer (320 views)
Cancer Detect Prev (ISSN: 0361-090x, 0361-090xlinking), 1999; 23(2): 116-122.
Impact Factor: 0.927
View Export to BibTeX Export to EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (314 views)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
View Export to BibTeX Export to EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (292 views)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
View Export to BibTeX Export to EndNote
Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, Bozzao L, Lenzi GL, Salvatore M, Conforti P
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography (600 views) (PDF 287 views)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 1988 Sep; 51(8): 1058-1062.
Impact Factor: 3.041
View Export to BibTeX Export to EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2711 views)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models (3 views)
Acs Appl Mater Interfaces (ISSN: 1944-8252electronic), 2022 Mar 09; 14 (9 ): 11078-11091.
Impact Factor:
View Export to BibTeX Export to EndNote
Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F, Fagoonee S
* The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells (4 views)
Cancers (ISSN: 2072-6694linking), 2021 Aug 13; 13(16): N/D-N/D.
Impact Factor: 6.126
View Export to BibTeX Export to EndNote
Susana F, Fagoonee S, Alessandro S, Valentina G, Chiara R, Marco P, Fiorella A, Danilo D
* Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring (82 views)
Talanta (ISSN: 0039-9140linking), 2021 Jan 15; 222: 121441-121441.
Impact Factor: 5.339
View Export to BibTeX Export to EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (149 views) (PDF 45 views)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
View Export to BibTeX Export to EndNote
Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, Altruda F, Fagoonee S
* Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells (128 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2020 Jan 16; 21 (2 ): N/D-N/D.
Impact Factor: 2.598
View Export to BibTeX Export to EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (133 views)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
View Export to BibTeX Export to EndNote
Barresi V, Valenti G, Spampinato G, Musso N, Castorina S, Rizzarelli E, Condorelli DF
* Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer (185 views)
J Cell Biochem (ISSN: 0730-2312linking), 2018 Dec; 119(12): 9707-9719.
Impact Factor: 2.959
View Export to BibTeX Export to EndNote
Di Lascio N, Avigo C, Salvati A, Martini N, Ragucci M, Monti S, Prinster A, Chiappino D, Mancini M, D'Elia D, Ghiadoni L, Bonino F, Brunetto MR, Faita F
* Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging (427 views)
Ultrasound Med Biol (ISSN: 0301-5629, 0301-5629linking), 2018; 44(8): 1585-1596.
Impact Factor: 2.494
View Export to BibTeX Export to EndNote
Caprio MG, Simonetti I, Tarotto L, Trovato P, Mainolfi CG, Salvatore B, Pace L
* 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (163 views) (PDF 157 views)
Int J Of Current Res, 2017 Jul; 9: 53960-53964.
Impact Factor: 7.086
View Export to BibTeX Export to EndNote
Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (365 views)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2016 Dec 28; 8(6): 10007-10024.
Impact Factor: 5.168
View Export to BibTeX Export to EndNote
Caviglia GP, Cabianca L, Fagoonee S, Gili FM
* Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase (329 views)
Biochem Medica (ISSN: 1330-0962), 2016; 26(1): 114-120.
Impact Factor: 2.934
View Export to BibTeX Export to EndNote
Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, Vita G, Venetucci A, Di Cosola M, Barbato F, Storto G
* [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients (219 views)
Radiol Oncol (ISSN: 1318-2099), 2015 Nov 27; 49(4): 320-326.
Impact Factor: 1.736
View Export to BibTeX Export to EndNote
Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S
* Non-invasive diagnostic imaging of colorectal liver metastases (254 views)
World J Radiol (ISSN: 1949-8470electronic, 1949-8470linking), 2015 Jul 28; 7(7): 157-169.
Impact Factor: 0.567
View Export to BibTeX Export to EndNote
Petretta M, Storto G, Pellegrino T, Bonaduce D, Cuocolo A
* Quantitative Assessment of Myocardial Blood Flow with SPECT (380 views)
Prog Cardiovasc Dis (ISSN: 0033-0620), 2015 Jan 3; 57(6): 607-614.
Impact Factor: 4.635
View Export to BibTeX Export to EndNote
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (397 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S425-S425.
Impact Factor: 5.537
View Export to BibTeX Export to EndNote
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (409 views)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
View Export to BibTeX Export to EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (531 views)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
View Export to BibTeX Export to EndNote
Napolitano S, Troiani T, Morgillo F, Ciardiello F, Belli G, Cioffi L, Sirignano C, Martinelli E
* Predictive Biomarkers To Anti-Egfr Inhibitors Treatment In The Management Of Metastatic Colorectal Cancer (245 views) (PDF 12 views)
Journal Of Carcinogenesis & Mutagenesis, 2014; N/D: 2157-2518.
Impact Factor: 3.445
View Export to BibTeX Export to EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (672 views)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
View Export to BibTeX Export to EndNote
Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (334 views)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
View Export to BibTeX Export to EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (442 views)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
View Export to BibTeX Export to EndNote
Matrone A, Russo M, Mollica C, Lombardi D, Lombardi G, Maurea S, Imbriaco M
* Lymphoepithelial pancreatic cyst: an atypical benign pancreatic mass presenting with a "cheerios-like" appearance (315 views)
Jop (ISSN: 1590-8577, 1590-0857), 2010 Mar 5; 11(2): 170-172.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro, Merlino A, Graziano G, Colantuoni V
* A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia (410 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Impact Factor: 2.773
View Export to BibTeX Export to EndNote
Lucignani G, Cuocolo A
Advances in quantitative assessment of myocardial blood flow and coronary reserve (230 views)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2009 Oct; 36(10): 1687-1692.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (250 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (371 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (250 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
View Export to BibTeX Export to EndNote
Mainenti PP, Cirillo LC, Camera L, Persico F, Cantalupo T, Pace L, De Palma GD, Persico G, Salvatore M
* Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer (321 views)
Eur J Radiol (ISSN: 0720-048x), 2006 Dec; 60(3): 453-459.
Impact Factor: 1.332
View Export to BibTeX Export to EndNote
Caprio MG, Cantalupo T, Mainenti PP, Mainolfi CG, Varrone A, Salvatore B, Persico F, D'Antonio D, Pace L, Salvatore M
* 18F-fdg pet, pet/ct and ce-mdct in locally advanced colorectal cancer (282 views) (PDF 157 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Storto G, Mainenti PP, Varrone A, Mainolfi C, Salvatore B, Caprio MG, Cella L, Soricelli A, Pace L, Salvatore M
* Role of FDG-PET/CT in the staging of colorectal cancer (382 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Mainenti PP, Romano M, Imbriaco M, Camera L, Pace L, D'Antonio D, Bucci L, Galloro G, Salvatore M
* Added value of CT colonography after a positive conventional colonoscopy: Impact on treatment strategy (401 views)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2005 Jan; 30(1): 42-47.
Impact Factor: 1.034
View Export to BibTeX Export to EndNote
Salvatore M, Fonti R
* New frontiers of nuclear medicine (455 views)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 May; 88(3): S60-S60.
Impact Factor: 0.267
View Export to BibTeX Export to EndNote
Esposito G, Tempesta A, Galati MG, De Bellis M, Rossi GB, Potena MI, Marone P, Daniele B, Del Vecchio S
Mucosal expression of carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with gastritis and gastric cancer (320 views)
Cancer Detect Prev (ISSN: 0361-090x, 0361-090xlinking), 1999; 23(2): 116-122.
Impact Factor: 0.927
View Export to BibTeX Export to EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (314 views)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
View Export to BibTeX Export to EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (292 views)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
View Export to BibTeX Export to EndNote
Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, Bozzao L, Lenzi GL, Salvatore M, Conforti P
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography (600 views) (PDF 287 views)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 1988 Sep; 51(8): 1058-1062.
Impact Factor: 3.041
View Export to BibTeX Export to EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2711 views)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
View Export to BibTeX Export to EndNote
37 Records (31 excluding Abstracts).
Total impact factor: 114.407 (92.36 excluding Abstracts).
Total 5 year impact factor: 92.716 (69.414 excluding Abstracts).
Total impact factor: 114.407 (92.36 excluding Abstracts).
Total 5 year impact factor: 92.716 (69.414 excluding Abstracts).
297 views. Last view on Saturday 14 January 2023, 17:48:16
ibb.cnr.it
